Projected Income Statement: DR Horton

Forecast Balance Sheet: DR Horton

Forecast Balance Sheet - DR Horton
Fiscal Period: September 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 2,202 3,526 1,221 1,401 2,980 3,031 3,669 3,842
Change - 60.13% -65.37% 14.74% 112.71% 1.71% 21.05% 4.72%
Announcement Date 11/9/21 11/9/22 11/7/23 10/29/24 10/28/25 - - -
1USD in Million
Estimates

Cash Flow Forecast: DR Horton

Fiscal Period: September 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 267.4 148.2 148.6 165.3 137.4 145.6 151.4 169
Change - -44.58% 0.27% 11.24% -16.88% 6% 3.98% 11.6%
Free Cash Flow (FCF) 1 267 413.6 4,156 2,024 3,284 3,491 2,688 -
Change - 54.91% 904.71% -51.28% 62.19% 6.31% -23% -100%
Announcement Date 11/9/21 11/9/22 11/7/23 10/29/24 10/28/25 - - -
1USD in Million
Estimates

Forecast Financial Ratios: DR Horton

Fiscal Period: September 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 18.76% 21.66% 15.47% 15.34% 12.63% 13% 13.3% 14.23%
EBIT Margin (%) 17.29% 20.68% 14.63% 14.53% 11.78% 10.91% 11.18% 11.21%
EBT Margin (%) 19.29% 22.79% 17.81% 17.08% 13.84% 12.29% 12.12% 12.6%
Net margin (%) 15.03% 17.5% 13.38% 12.92% 10.47% 9.06% 9.02% 9.52%
FCF margin (%) 0.96% 1.24% 11.72% 5.5% 9.59% 10.65% 7.82% -
FCF / Net Income (%) 6.39% 7.06% 87.56% 42.56% 91.58% 117.57% 86.72% -

Profitability

        
ROA 19.47% 21.55% 15.08% 13.85% 10.02% 7.75% 8.5% 10.9%
ROE 31.25% 34.17% 22.55% 19.81% 14.48% 12.31% 13.1% 14.95%

Financial Health

        
Leverage (Debt/EBITDA) 0.42x 0.49x 0.22x 0.25x 0.69x 0.71x 0.8x 0.73x
Debt / Free cash flow 8.25x 8.53x 0.29x 0.69x 0.91x 0.87x 1.36x -

Capital Intensity

        
CAPEX / Current Assets (%) 0.96% 0.44% 0.42% 0.45% 0.4% 0.44% 0.44% 0.46%
CAPEX / EBITDA (%) 5.13% 2.04% 2.71% 2.93% 3.18% 3.42% 3.31% 3.22%
CAPEX / FCF (%) 100.15% 35.83% 3.58% 8.16% 4.18% 4.17% 5.63% -

Items per share

        
Cash flow per share 1 1.461 1.583 12.54 6.604 11.04 9.345 7.481 -
Change - 8.39% 691.8% -47.33% 67.16% -15.35% -19.94% -
Dividend per Share 1 0.8 0.925 1.025 1.2 1.6 1.792 1.918 2.107
Change - 15.62% 10.81% 17.07% 33.33% 12.03% 6.97% 9.87%
Book Value Per Share 1 41.81 56.39 67.78 78.12 82.15 86.64 91.49 97.63
Change - 34.87% 20.2% 15.26% 5.16% 5.46% 5.6% 6.71%
EPS 1 11.41 16.51 13.82 14.34 11.57 10.42 11.47 13.8
Change - 44.7% -16.29% 3.76% -19.32% -9.9% 10.07% 20.23%
Nbr of stocks (in thousands) 358,194 347,481 338,297 325,839 298,124 279,701 279,701 279,701
Announcement Date 11/9/21 11/9/22 11/7/23 10/29/24 10/28/25 - - -
1USD
Estimates
2026 *2027 *
P/E 13.1x 11.9x
PBR 1.58x 1.49x
EV / Sales 1.26x 1.22x
Yield 1.31% 1.4%

EPS & Dividend

EPS & Dividend - DR Horton


Y-o-Y evolution of P/E

Valuation ratios - P/E - DR Horton
 

Year-on-year evolution of the Yield

Valuation ratios - Yield - DR Horton
Trader
Investor
Global
Quality
ESG MSCI
AA
Ratings Surperformance© - DR Horton
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
136.75USD
Average target price
157.46USD
Spread / Average Target
+15.15%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - DR Horton